ライフサイエンスコーパス: diastolic blood pressure

1 6 months (p=0.0003 for systolic and p=0.0001 diastolic blood pressure).

2 7-16) at 6 months (p<0.0001 for systolic and diastolic blood pressure).

3 l but clinically irrelevant decrease in mean diastolic blood pressure.

4 c hypertension was modeled as a reduction in diastolic blood pressure.

5 tients in cohort 4 had asymptomatic drops in diastolic blood pressure.

6 ociation with periodontitis, except for high diastolic blood pressure.

7 % CI, -5.6 to -2.5; 6 studies; I2 = 17%) for diastolic blood pressure.

8 The pattern of results was similar for diastolic blood pressure.

9 glycerides, HDL-c, glucose, and systolic and diastolic blood pressure.

10 nmental factors associated with systolic and diastolic blood pressure.

11 lar associations were observed with systolic/diastolic blood pressure.

12 tolic blood pressure and clinic systolic and diastolic blood pressures.

13 Hg (95% CI: 2.5, 8.8 mm Hg; P = 0.0005) for diastolic blood pressure].

14 .37 mm Hg [95% CI -2.15 to 1.40]; p=0.43) or diastolic blood pressure (0.01 mm Hg [-1.29 to 1.32]; p=

15 0.24) resting heart rate and slightly higher diastolic blood pressure (0.05 mm Hg; 95% confidence int

16 01; p=0.0498) and a change of -0.08 mm Hg in diastolic blood pressure (-0.15 to -0.02; p=0.01).

17 CI, -1.77 to -0.75]; 22 trials [n = 57953]), diastolic blood pressure (-0.49 mm Hg [95% CI, -0.82 to

18 s associated with a change of -0.29 mm Hg in diastolic blood pressure (-0.52 to -0.07; p=0.01), a cha

19 pressure 0.0455 (95% CI 0.00137-0.0897), and diastolic blood pressure -0.0674 (95% CI -0.126--0.00889

20 , 0.45 (95% CI 0.06-0.84; p < 0.02) mm Hg in diastolic blood pressure, 0.01 ml/min/1.73 m2 (95% CI 0.

21 for systolic and 0.8 mm Hg (-0.6 to 2.3) for diastolic blood pressure; -0.1 mmol/L (-0.2 to 0.1) for

22 tolic blood pressure, -1.6 mm Hg/y, P=0.018; diastolic blood pressure, -1.3 mm Hg/y, P=0.002; nightti

23 tolic blood pressure: -1.9 mm Hg/y, P=0.008; diastolic blood pressure: -1.3 mm Hg/y, P=0.014), which

24 domly assigned to less-tight control (target diastolic blood pressure, 100 mm Hg) or tight control (t

25 lic (-32.0 mm Hg, 95% CI -35.7 to -28.2) and diastolic blood pressure (-14.4 mm Hg, -16.9 to -11.9).

26 re (-3.64 mm Hg; 95% CI: -7.36, 0.08 mm Hg), diastolic blood pressure (-2.48 mm Hg; 95% CI: -4.98, 0.

27 systolic (-8.9 +/- 18.7 mmHg, P < 0.001) and diastolic blood pressure (-2.6 +/- 14.5 mmHg, P = 0.04),

28 Besides reduction of systolic and diastolic blood pressure (-22.5/-7.2 mm Hg at 1 month an

29 pressure outcomes (29 SNPs for systolic and diastolic blood pressure, 22 SNPs for mean arterial pres

30 kg), waist circumference (-3.1 +/- 1.4 cm), diastolic blood pressure (-4.1 +/- 1.6 mmHg), heart rate

31 ed, decreases were observed for systolic and diastolic blood pressure (-5 +/- 1 and -4 +/- 1 mm Hg, r

32 ficantly greater mean (+/- SE) reductions in diastolic blood pressure (-5.0 +/- 1.7 mm Hg compared wi

33 an heart rate (88 vs 99 beats/min; p<0.001), diastolic blood pressure (60 vs 66 mm Hg; p=0.007), shoc

34 1427 versus 2291 pmol/L; P<0.001) and higher diastolic blood pressures (75 versus 73 mm Hg; P=0.009)

35 +/- 2 y; systolic blood pressure: 135 +/- 1; diastolic blood pressure: 80 +/- 1 mm Hg) underwent a hi

36 ressure, 100 mm Hg) or tight control (target diastolic blood pressure, 85 mm Hg).

37 systolic blood pressure 140 mm Hg or higher, diastolic blood pressure 90 mm Hg or higher, or receivin

38 Retirement was accompanied by a reduction in diastolic blood pressure, a slowdown in the increase of

39 e: -5.1 mm Hg; 95% CI: -8.2, -2.1 mm Hg) and diastolic blood pressure (adjusted difference: -3.2 mm H

40 Control donors showed a rise in diastolic blood pressure after donation, and thus the pr

41 There were no changes in diastolic blood pressure after either dietary condition.

42 ejection fraction and creatinine but higher diastolic blood pressure (all P<0.001).

43 , we found significantly higher systolic and diastolic blood pressures among those who entered or con

44 larly, in a model that included systolic and diastolic blood pressure and additional risk factors dur

45 l resulted in a decrease in 24-hour mean and diastolic blood pressure and an improvement in the noctu

46 Diastolic blood pressure and baseline AAA diameter were

47 ary end points included change in ambulatory diastolic blood pressure and clinic systolic and diastol

48 Although systolic and diastolic blood pressure and color Doppler indices did n

49 ele was associated with reduced systolic and diastolic blood pressure and decreased total and HDL cho

50 roke and systemic embolism included elevated diastolic blood pressure and heart rate, as well as vasc

51 flavanol ingestion alone decreased bPWV and diastolic blood pressure and increased CACs.

52 iated with lower systolic blood pressure and diastolic blood pressure and lower hypertension risk, bu

53 P = 7.00 x 10(-5) and P = 7.23 x 10(-5) for diastolic blood pressure and MAP responses, respectively

54 Moreover, baseline diastolic blood pressure and the change in systolic bloo

55 d hormone was related to higher systolic and diastolic blood pressures and arterial pressure at week

56 Higher cumulative systolic and diastolic blood pressures and fasting blood glucose were

57 lesterols, serum triglycerides, systolic and diastolic blood pressures and glycated haemoglobin in th

58 uses on the association between systolic and diastolic blood pressures and the risk of cardiovascular

59 In parallel, systolic and diastolic blood pressures and triglyceride, total choles

60 estlessness), cardiovascular (pulse rate and diastolic blood pressure), and brain DA [reduced decreas

61 r plasma CHGA levels, plasma glucose levels, diastolic blood pressure, and body mass index.

62 ensity lipoprotein cholesterol, systolic and diastolic blood pressure, and fasting glucose were measu

63 lipoprotein (HDL) cholesterol, systolic and diastolic blood pressure, and fasting glucose were measu

64 lood glucose, HbA1c, age, systolic (SBP) and diastolic blood pressure, and grade of retinopathy.

65 in biological (body-mass index, systolic and diastolic blood pressure, and handgrip strength), behavi

66 , systolic and mean perfusion pressures, low diastolic blood pressure, and high systolic and mean art

67 rol concentrations, systolic blood pressure, diastolic blood pressure, and homeostasis model assessme

68 gher New York Heart Association class, lower diastolic blood pressure, and no angiotensin II receptor

69 icant increases were detected in systolic or diastolic blood pressure, and no heterogeneity was obser

70 Hemodynamic parameters (mean, systolic, and diastolic blood pressure, and rate of pressure increase)

71 rterial stiffness, reduced mean arterial and diastolic blood pressure, and reduced carotid intima med

72 ce significantly increased both systolic and diastolic blood pressure, and this was not affected by S

73 vival correlated with NYHA functional class, diastolic blood pressure, and use of diuretic agents.

74 androsterone sulfate, cortisol, systolic and diastolic blood pressure, and waist-to-hip ratio.

75 low HDL cholesterol level, high systolic and diastolic blood pressures, and high triglyceride and gly

76 Smoking cessation and control of diastolic blood pressure are direct actions that should

77 High systolic and diastolic blood pressures are independent and significan

78 fee, and caffeine with measured systolic and diastolic blood pressures at annual visit 3 in 29,985 po

79 ome) showed no association between PM2.5 and diastolic blood pressure (b = -0.41 mmHg; 95% confidence

80 ant decrease in heart rate, and systolic and diastolic blood pressure before and after yoga (p < 0.00

81 Systolic and diastolic blood pressures before each event were average

82 Hypotension was defined as systolic and/or diastolic blood pressure below the fifth percentile for

83 Also, those with a high diastolic blood pressure benefitted more from surgery th

84 5% CI, 0.78-2.52 mm Hg; P = 2.0 x 10-04) and diastolic blood pressure (beta = 1.37 mm Hg; 95% CI, 0.8

85 0.97-0.99; p=0.0003), but not with decreased diastolic blood pressure (beta per 10% increase, -0.02 m

86 ic blood pressure between 120 and 139 mm Hg, diastolic blood pressure between 80 and 89 mm Hg, or bot

87 cholesterol, lipoprotein A, and systolic and diastolic blood pressure between European Americans and

88 systolic and 3.1 mm Hg (95% CI, 0.7-5.5) for diastolic blood pressure between groups.

89 esity, high systolic blood pressure, or high diastolic blood pressure between midchildhood and early

90 amples with significant effects preserved on diastolic blood pressure, body mass index, and fasting g

91 phism rs11625658 on systolic blood pressure, diastolic blood pressure, body mass index, and fasting g

92 sk factors such as gender, age, systolic and diastolic blood pressures, body mass index (BMI), fastin

93 otoxin, resiniferatoxin, selectively lowered diastolic blood pressure both at daytime and night-time

94 Hg (95% CI: -1.72, -0.19), respectively, for diastolic blood pressure (both P 's = 0.014).

95 , there was a reduction in mean systolic and diastolic blood pressure (BP) at 6 months of -28.9 mm Hg

96 the definition of hypertension, systolic and diastolic blood pressure (BP) thresholds for initiation

97 Systolic and diastolic blood pressure (BP) were recorded as the mean

98 sterol, triglycerides, glucose, systolic and diastolic blood pressure (BP), and the metabolic syndrom

99 We observed reductions in diastolic blood pressure (BP; -1.60 mm Hg; 95% CI: -2.77

100 with acute respiratory infection and reduced diastolic blood pressure but not with other health measu

101 intake was associated with mean systolic or diastolic blood pressure, but decaffeinated coffee intak

102 s in the adjusted mean change in systolic or diastolic blood pressure by quartile of 25(OH)D.

103 e contraction, and decreases in systolic and diastolic blood pressures by 4 to 6 and 1 to 2 mm Hg, re

104 erapy was also associated with a decrease in diastolic blood pressure (by 2.0 mm Hg vs. 0.0 mm Hg, P=

105 T-wave), heart rate turbulence, systolic and diastolic blood pressures, C-reactive protein, and fibri

106 mentation significantly reduced systolic and diastolic blood pressures, cardiac fibrosis, and left ve

107 fferent neurotoxin, RTX, selectively lowered diastolic blood pressure CHF rats.

108 suming 3500 mg/d or more had generally lower diastolic blood pressures compared with individuals cons

109 No treatment effect on either systolic or diastolic blood pressure could be detected.

110 AF comprised of height, weight, systolic and diastolic blood pressure, current smoking status, antihy

111 olic blood pressure (SBP) >/=120 mmHg and/or diastolic blood pressure (DBP) >/=80 mmHg (per 2 allele

112 Increasing age, baseline diastolic blood pressure (DBP) >/=90 mm Hg, history of c

113 stolic blood pressure (SBP) >/=140 mm Hg and diastolic blood pressure (DBP) <90 mm Hg, in younger and

114 s were similar for each 10 mmHg increment in diastolic blood pressure (DBP) (p < 0.001) or each 15 mm

115 nce (WC), systolic blood pressure (SBP), and diastolic blood pressure (DBP) 16 y after pregnancy.

116 calculated as ratio of the gradient between diastolic blood pressure (DBP) and left ventricular end-

117 al in both systolic blood pressure (SBP) and diastolic blood pressure (DBP) between the magnesium-sup

118 eased 24-h systolic blood pressure (SBP) and diastolic blood pressure (DBP) by 3.0 mmHg and 1.5 mmHg,

119 vival depends on attaining adequate arterial diastolic blood pressure (DBP) during CPR, the American

120 iated with systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Europeans.

121 (GL) with systolic blood pressure (SBP) and diastolic blood pressure (DBP) in healthy individuals.A

122 ter during decreasing compared to increasing diastolic blood pressure (DBP) in young men and women.

123 By contrast, a baseline diastolic blood pressure (DBP) less than 70 mm Hg was as

124 g or greater and less than 180 mm Hg, office diastolic blood pressure (DBP) of 90 mm Hg or greater, a

125 The change in diastolic blood pressure (DBP) over time was significant

126 Diastolic blood pressure (DBP) tended to increase until

127 owever, achieving an SBP this low may reduce diastolic blood pressure (DBP) to levels that could comp

128 tions with systolic blood pressure (SBP) and diastolic blood pressure (DBP) using the Candidate Gene

129 s 101.2 +/- 9.0 and 102.1 +/- 9.3 mm Hg, and diastolic blood pressure (DBP) was 54.5 +/- 7.3 and 55.8

130 The mean diastolic blood pressure (DBP) was lower in men with ast

131 Office systolic blood pressure (SBP) and diastolic blood pressure (DBP) were 4.9 +/- 1.7 mm Hg (P

132 electin), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were assessed.

133 xposure to systolic blood pressure (SBP) and diastolic blood pressure (DBP) were associated with lowe

134 Results for diastolic blood pressure (dBP) were similar.

135 blood pressure (SBP) or >/=10 mm Hg drop in diastolic blood pressure (DBP) within 3 min from postura

136 tolic blood pressure (SBP), 144.2 mm Hg; and diastolic blood pressure (DBP), 83 mm Hg.

137 AT on both systolic blood pressure (SBP) and diastolic blood pressure (DBP), accounting for approxima

138 sociations of systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate with AChE

139 e age of 7 y, systolic blood pressure (SBP), diastolic blood pressure (DBP), and the prevalence of ch

140 alysis for systolic blood pressure (SBP) and diastolic blood pressure (DBP), followed by trait-marker

141 In individuals with a low diastolic blood pressure (DBP), the potential benefits o

142 adulthood systolic blood pressure (SBP) and diastolic blood pressure (DBP).

143 can reduce systolic blood pressure (SBP) and diastolic blood pressure (DBP).

144 io (WHtR), systolic blood pressure (SBP) and diastolic blood pressure (DBP).

145 tive LASSO, whereas only Ni was selected for diastolic blood pressure (DBP).

146 stolic blood pressure (SBP): -3.9 mm Hg; for diastolic blood pressure (DBP): -2.5 mm Hg; P = 0.050 fo

147 ycerides, systolic blood pressure (SBP), and diastolic blood pressure (DBP); and lower high-density l

148 challenge and implies a persistent systolic/diastolic blood pressure decrease of at least 20/10 mm H

149 (95% CI, 0.1% to 0.7%) (n = 8); systolic and diastolic blood pressure decreased by 3.68 mm Hg (CI, 1.

150 Average systolic/diastolic blood pressure decreased from 142.6/77.1 mm Hg

151 ersus -3.55 (95% CI: -4.17, -2.93) mm Hg and diastolic blood pressure decreases of -2.25 (95% CI: -3.

152 use, servings of FV, white blood cell count, diastolic blood pressure, diabetes, nonsteroidal antiinf

153 d: male sex, greater body mass index, higher diastolic blood pressure, elevated jugular venous pressu

154 k Heart Association (NYHA) functional class, diastolic blood pressure, estimated glomerular filtratio

155 Older age and higher diastolic blood pressure, even within the normal range,

156 , triglycerides, fat mass (FM), systolic and diastolic blood pressure, fasting insulin and glucose, a

157 eas under the curve for resting systolic and diastolic blood pressures, fasting blood glucose, and to

158 systolic and 3.4 mm Hg (95% CI, 1.8-5.0) in diastolic blood pressure following correction for baseli

159 in systolic blood pressure and 0.78 mm Hg in diastolic blood pressure for each 1-g increment in estim

160 high income) showed a 1.52-mmHg increase in diastolic blood pressure for each 10-microg/m(3) increas

161 ic exposure had a greater annual increase in diastolic blood pressure for water arsenic and urinary c

162 roup had significantly greater reductions in diastolic blood pressure from baseline than both nebivol

163 p differences in the changes in systolic and diastolic blood pressure from baseline to 12 months in a

164 Outcomes included systolic and diastolic blood pressure from the average of 3 measures

165 (from 181 +/- 7 to 156 +/- 5, p < 0.001) and diastolic blood pressure (from 97 +/- 6 to 87 +/- 4, p <

166 Donor gender, body mass index, diastolic blood pressure, glomerular filtration rate, an

167 ly concordant association of rs10749571 with diastolic blood pressure, glucose and triglyceride level

168 eurologic deficit (LR, 4.7; 95% CI, 1.6-14), diastolic blood pressure greater than 110 mm Hg (LR, 4.3

169 systolic blood pressure >/= 130 mm Hg and/or diastolic blood pressure >/= 85 mm Hg or medication for

170 [systolic blood pressure (SBP) >/=130 mm Hg, diastolic blood pressure >/=80 mm Hg, or both] received

171 ned as systolic blood pressure >/=140 mm Hg, diastolic blood pressure >/=90 mm Hg, or initiation of a

172 (systolic blood pressure [SBP] >/=140 mm Hg, diastolic blood pressure >/=90 mm Hg, or initiation of b

173 ned as systolic blood pressure >/=140 mm Hg, diastolic blood pressure >/=90 mm Hg, or use of antihype

174 ined as systolic blood pressure >/=140 mmHg, diastolic blood pressure >/=90 mmHg, and/or self-reporte

175 peripheral arterial disease, whereas raised diastolic blood pressure had a greater effect on abdomin

176 sex, race, BMI, smoking, total cholesterol, diastolic blood pressure, HbA1c, treatment, estimated gl

177 netic associations of SNPs with systolic and diastolic blood pressure, HDL cholesterol, and triglycer

178 epoetin alfa, postrandomization systolic and diastolic blood pressure, hemoglobin level, platelet cou

179 autonomic function (heart rate, systolic and diastolic blood pressures), hemostasis (von Willebrand f

180 n D deficiency showed increased systolic and diastolic blood pressure, high plasma renin, and decreas

181 ted with several cardiometabolic biomarkers (diastolic blood pressure, high-density lipoprotein chole

182 od pressure (HR = 0.96, 95% CI: 0.84, 1.10), diastolic blood pressure (HR = 0.96, 95% CI: 0.87, 1.06)

183 reductase (MTHFR) have been associated with diastolic blood pressure, hypertension, and other cardio

184 atus and smoking heaviness with systolic and diastolic blood pressure, hypertension, and resting hear

185 enal artery denervation reduces systolic and diastolic blood pressure in patients with drug-resistant

186 We detected strong associations between diastolic blood pressure in the UK Biobank and both the

187 We found that higher maternal systolic and diastolic blood pressures in early pregnancy were associ

188 Diastolic blood pressure increased dose dependently in m

189 Systolic and diastolic blood pressure increased, whereas blood lactat

190 pring BMI, waist circumference, systolic and diastolic blood pressures, insulin, and triglycerides an

191 y of dyslipidaemia, coronary artery disease, diastolic blood pressure, intraoperative shunt use and n

192 concerns for reduced myocardial perfusion if diastolic blood pressure is too low.

193 ht cardiometabolic traits (BMI, systolic and diastolic blood pressure, LDL cholesterol, HDL cholester

194 d mean baseline office and 24-h systolic and diastolic blood pressure levels were 154 (14)/90 (11) mm

195 childhood cholesterol levels or systolic or diastolic blood-pressure levels on a continuous scale, a

196 ociated with self-reported IHD, systolic and diastolic blood pressure, low-density lipoprotein- and t

197 w-risk status, defined as untreated systolic/diastolic blood pressure </=120/</=80 mm Hg, untreated s

198 e medications while maintaining systolic and diastolic blood pressure <140 mm Hg and 90 mm Hg, respec

199 e; 2) systolic blood pressure <130 mm Hg and diastolic blood pressure <85 mm Hg (<80 mm Hg if diabeti

200 d several cis-eGenes (ALDH2 for systolic and diastolic blood pressure, MCM6 and DARS for total choles

201 tral systolic blood pressure (cSBP), central diastolic blood pressure, mean arterial pressure (MAP),

202 able trends were noted for mean systolic and diastolic blood pressure, mean concentrations of total c

203 individuals provided 1,342,814 systolic and diastolic blood pressure measurements for a genome-wide

204 lasma cortisol, heart rate, and systolic and diastolic blood pressure measures were obtained.

205 A greater fall in diastolic blood pressure occurred in the positive airway

206 ystolic blood pressure of <80 or >200 mm Hg, diastolic blood pressure of >110 mm Hg, and peripheral o

207 ith significant changes in mean systolic and diastolic blood pressure of -1.76 mm Hg (95% confidence

208 , and increased blood pressure (systolic and diastolic blood pressure of 1.21 mmHg [per-allele P = 2

209 al p-value of 0.000302, for association with diastolic blood pressure of 60,396 individuals.

210 ry outcome (adjusted HR 1.41 [1.24-1.61] for diastolic blood pressure of 60-69 mm Hg and 2.01 [1.50-2

211 systolic blood pressure of 90-114 mm Hg and diastolic blood pressure of 60-74 mm Hg, with no evidenc

212 olic blood pressure of 140 mm Hg or more and diastolic blood pressure of 80 mm Hg or more were each a

213 erall survival was longer in patients with a diastolic blood pressure of 90 mm Hg or greater than in

214 c blood pressure of 140 mm Hg or higher or a diastolic blood pressure of 90 mm Hg or higher based on

215 existing or gestational hypertension, office diastolic blood pressure of 90 to 105 mm Hg (or 85 to 10

216 lic blood pressure of at least 140 mm Hg, or diastolic blood pressure of at least 90 mm Hg, or self-r

217 sure of 60-69 mm Hg and 2.01 [1.50-2.70] for diastolic blood pressure of less than 60 mm Hg).

218 Likewise, diastolic blood pressure of less than 70 mm Hg was assoc

219 ic blood pressure of less than 120 mm Hg and diastolic blood pressure of less than 70 mm Hg were each

220 of 90 mm Hg or greater than in those with a diastolic blood pressure of less than 90 mm Hg: 20.7 mon

221 Both systolic and diastolic blood pressures of the Nr2f2(mutant) rats are

222 mbers of patients treated per center, higher diastolic blood pressure, off-hour admission, and absenc

223 blood pressure 160 vs 110 mm Hg) but not for diastolic blood pressure or lipid measures with VTE.

224 ctively), but not with childhood systolic or diastolic blood pressure or mean arterial pressure.

225 Diastolic blood pressure (OR, 0.74; 95% CI, 0.65-0.84, p

226 5% CI, 1.00-1.02 per 1-mmHg increase), lower diastolic blood pressure (OR, 0.97; 95% CI, 0.96-0.99 pe

227 .34; 95% CI: 1.05, 1.70), and new-onset high diastolic blood pressure (OR: 1.25; 95% CI: 0.99, 1.58)

228 dpoint of 24-h mean systolic blood pressure, diastolic blood pressure, or stress-induced changes in b

229 PO levels also significantly correlated with diastolic blood pressure over the time course.

230 The TORe group had reduced systolic and diastolic blood pressure (P < .001) and a trend toward i

231 a dose-response improvement in systolic and diastolic blood pressure (p < 0.001), total cholesterol

232 terol, glucose, systolic blood pressure, and diastolic blood pressure (P </= 0.02 for each).

233 s positively related to prepregnancy BMI and diastolic blood pressure (P <0.05).

234 age region was significantly associated with diastolic blood pressure (P = 0.0007) and MAP responses

235 gene (VSNL1)) was marginally associated with diastolic blood pressure (P = 0.005) and MAP responses (

236 included and non-included groups except for diastolic blood pressure (p = 0.037).

237 ors for NSD were high values of systolic and diastolic blood pressure (p = 0.039 and 0.043 respective

238 more from surgery than did those with a low diastolic blood pressure (p for interaction = 0.028).

239 associated with both systolic (P=0.001) and diastolic blood pressures (P=8.3x10(-04)).

240 1; gender, P < 0.001; heart rate, P < 0.001; diastolic blood pressure, P < 0.001; weight, P = 0.001),

241 d with overall SBP (pcom = 7.0 x 10(-8)) and diastolic blood pressure (pcom = 2.8 x 10(-4)).

242 e investigated body-mass index, systolic and diastolic blood pressure, plasma glucose concentration,

243 rogen, higher systolic blood pressure, lower diastolic blood pressure, previous weight gain, and lowe

244 Systolic and diastolic blood pressure profiles validated the benefici

245 ystolic blood pressure [r=0.29, P<0.001] and diastolic blood pressure [r=0.28, P<0.001]).

246 Compared with diastolic blood pressure, raised systolic blood pressure

247 mination with LDX for pulse and systolic and diastolic blood pressure ranged from 4.41-6.31 b.p.m. an

248 ding age, sex, body mass index, systolic and diastolic blood pressure, ratio of fasting total cholest

249 Following both interventions, diastolic blood pressure reduced significantly with time

250 mic and hyperlipidemic men, with significant diastolic blood pressure reductions in the HYL group onl

251 he demonstration of significant systolic and diastolic blood pressure reductions.

252 5% CI: 0.86, 1.39 for new-onset systolic and diastolic blood pressure, respectively).

253 n the average rate of change in systolic and diastolic blood pressure, respectively, whereas family S

254 p24.1), with a maximum LOD score of 3.33 for diastolic blood pressure responses to high-sodium interv

255 A consistent trend was observed for diastolic blood pressure responses: -1.80 (95% CI: -2.41

256 sting, P=0.0002; peak exercise, P=0.007) and diastolic blood pressure (resting, P=0.005; peak exercis

257 tation (nitric oxide, rho = -0.66, P = 0.06; diastolic blood pressure, rho = 0.68, P = 0.04) and infl

258 EVA biomarkers included systolic and diastolic blood pressure (SBP and DBP), central pulse pr

259 Associations between systolic and diastolic blood pressure (SBP and DBP, respectively) and

260 al influence of homocysteine on systolic and diastolic blood pressure (SBP and DBP, respectively) in

261 ents occur among US adults with systolic and diastolic blood pressure (SBP/DBP) >/=140/90 mm Hg.

262 ty was significantly related to systolic and diastolic blood pressures (SBP and DBP) and ageing for b

263 o HDL cholesterol (TC:HDL), and systolic and diastolic blood pressures (SBP and DBP, respectively)].

264 glycosylated hemoglobin [HbA1c], systolic or diastolic blood pressure [SBP/DBP], total [TC] or HDL-ch

265 nee osteoarthritis, systolic blood pressure, diastolic blood pressure, serum albumin, and bipolar dis

266 Heart rate and diastolic blood pressure showed the same pattern.

267 iovascular markers (heart rate, systolic and diastolic blood pressure) showed significant increases f

268 ngestive heart failure, warfarin, age, race, diastolic blood pressure, stroke), and observed that all

269 m Hg systolic blood pressure and 70-79 mm Hg diastolic blood pressure subgroups as reference.

270 ts of dietary potassium on both systolic and diastolic blood pressures suggest that consuming more po

271 0.54), there was no strong association with diastolic blood pressure, systolic blood pressure, or hy

272 eighborhood poverty had significantly higher diastolic blood pressures than those who had never lived

273 1.74; 95% CI, 0.79 to 3.84), despite a mean diastolic blood pressure that was higher in the less-tig

274 he potassium to sodium ratio on systolic and diastolic blood pressures throughout adolescence and aft

275 Mean systolic and diastolic blood pressures throughout adolescence and at

276 d to variability in early growth and that in diastolic blood pressure to reduced physical activity.

277 status, postmenopausal hormone therapy use, diastolic blood pressure, total cholesterol, high-densit

278 body mass index, family history of diabetes, diastolic blood pressure, total cholesterol, smoking, an

279 hydrate diet group had greater reductions in diastolic blood pressure, triglyceride levels, and very-

280 , carotid atherosclerosis, hypertension, low diastolic blood pressure, type 2 diabetes mellitus (Asia

281 For diastolic blood pressure, urinary cesium was tentatively

282 t, heart rate, body mass index, systolic and diastolic blood pressure, use of antihypertensive and ch

283 nancy weight, prepregnancy BMI, systolic and diastolic blood pressure, VLDL cholesterol, and glucose

284 ween retirement and systolic blood pressure, diastolic blood pressure, waist circumference, body mass

285 56-5.56 mmHg, p = 0.017) and mean ambulatory diastolic blood pressure was 2.17 mmHg lower (95% CI 0.6

286 ase of around 1.5 mm Hg in mean systolic and diastolic blood pressure was followed by a reduction of

287 average rate of change in both systolic and diastolic blood pressure was greater among African-Ameri

288 analysis, a larger decrease in systolic and diastolic blood pressure was shown in the placebo group

289 linear regression analysis between MSNA and diastolic blood pressure was used to determine the gain

290 Age, untreated maxLDL, CAC, and diastolic blood pressure were independently associated w

291 Similar trends for diastolic blood pressure were observed.

292 Reductions in clinic diastolic blood pressure were significant for LCI699 1.0

293 However, higher body mass index and diastolic blood pressure were significantly associated w

294 Systolic and diastolic blood pressures were lower in summer than in w

295 Systolic and diastolic blood pressures were lower with aliskiren (bet

296 Systolic and diastolic blood pressures were measured with a standard

297 Mean systolic and diastolic blood pressures were significantly reduced (P

298 xpansion rate (95% CI, 0.25-0.28; P < .001), diastolic blood pressure with a 0.02 (0.01)-cm/y increas

299 reased systolic blood pressure and decreased diastolic blood pressure with increasing age, the princi

300 ; 15 trials, 1190 participants), and diurnal diastolic blood pressure (WMD, -1.3 points [95% CI, -2.2